©2022 Australasian Society of Clinical Immunology and Allergy (ASCIA)
ABN 45 615 521 452



Information updates

Support for people with primary immunodeficiencies

The ASCIA Immunodeficiency Strategy for Australia and New Zealand aims to enhance the important work of organisations that support  people with primary immunodeficiencies and their carers, and enable key issues to be addressed, including early diagnosis and improved access to appropriate treatments.

ASCIA commends the outstanding work in advocacy and patient support provided by the following organisations:

IDFA (Immune Deficiencies Foundation Australia) 

pdfIDFA 2022214.33 KB

IDFNZ (Immune Deficiencies Foundation New Zealand)

pdfIDFNZ Update 2022223.12 KB

pdfIDFNZ printed information order form123.96 KB

AusPIPS (Australian Primary Immunodeficiency Patient Support) 

pdfAusPIPS Update 202279.85 KB

HAE (Hereditary Angioedema) Australasia 

pdfHAE Australasia 20221.58 MB

This news item was issued on 31 May 2022 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand.